Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Kaempferol Potential treatment - pre-clinical evidence Natural product Antiviral Jan/15/2021 2 0
Palmitic acid Potential treatment - theoretical effect Natural product Antiviral Jan/15/2021 1 0
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Jan/15/2021 27 3
Convalescent plasma Emergency use authorization Experimental Antiviral Jan/15/2021 27 5
Mentha haplocalyx extract Potential treatment - pre-clinical evidence Natural product Antiviral Jan/15/2021 1 0
Maduramicin Potential treatment - pre-clinical evidence Experimental Antiviral Jan/15/2021 2 0
Ganoderma lucidum extract fraction RF3 Potential treatment - pre-clinical evidence Natural product Antiviral Jan/15/2021 1 0
Emetine Potential treatment - pre-clinical evidence Experimental Antiviral Jan/15/2021 6 0
Perilla frutescens extract Potential treatment - pre-clinical evidence Natural product Antiviral Jan/15/2021 1 0
Azelnidipine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/15/2021 1 0